Stock listing
NASDAQ:TYRA Tyra Biosciences, Inc. Stock
Home listing (NASDAQ) of Tyra Biosciences, Inc.
Follow Tyra Biosciences, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:TYRA
$19.34 USD +0.82 (+4.4%)
Close on Oct 19, 2026
- Day range
- $18.49 – $19.49 USDOct 19, 2026
- Volume
- 871,843 sharesOct 19, 2026
- Market value
- $1.33B USDAt the close on Oct 19, 2026 · price × 68.76M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:TYRA · Home | $19.34 USD | +0.82 (+4.4%) | 871,843 | $18.75 | $19.49 | $18.49 | $18.52 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 19, 2026 · NASDAQ:TYRA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $19.34 | +0.82 | +4.4% | $18.75 | $19.49 | $18.49 | 871,843 | |
| $18.52 | -0.52 | -2.7% | $19.09 | $19.09 | $18.26 | 648,972 | |
| $19.04 | +0.34 | +1.8% | $18.86 | $19.30 | $18.76 | 418,027 | |
| $18.70 | +0.14 | +0.8% | $18.44 | $18.83 | $18.25 | 483,997 | |
| $18.56 | -1.04 | -5.3% | $19.39 | $19.60 | $18.54 | 469,540 | |
| $19.60 | -0.34 | -1.7% | $19.73 | $20.03 | $19.51 | 334,413 | |
| $19.94 | -0.03 | -0.2% | $19.93 | $20.59 | $19.73 | 649,439 | |
| $19.97 | -0.42 | -2.1% | $20.12 | $20.17 | $19.50 | 792,255 | |
| $20.39 | +0.15 | +0.7% | $19.97 | $20.79 | $19.80 | 477,743 | |
| $20.24 | -0.69 | -3.3% | $20.93 | $20.99 | $19.60 | 763,383 | |
| $20.93 | +0.50 | +2.4% | $20.57 | $21.03 | $19.94 | 614,360 | |
| $20.43 | -0.58 | -2.8% | $21.25 | $21.39 | $20.17 | 1,047,667 | |
| $21.01 | -0.86 | -3.9% | $21.78 | $22.32 | $20.88 | 889,699 | |
| $21.87 | -0.11 | -0.5% | $22.19 | $22.45 | $21.70 | 1,034,684 | |
| $21.98 | +0.53 | +2.5% | $21.37 | $22.62 | $21.29 | 501,797 | |
| $21.45 | -0.31 | -1.4% | $21.57 | $21.93 | $21.00 | 824,582 | |
| $21.76 | -0.65 | -2.9% | $22.33 | $22.41 | $21.67 | 1,421,983 | |
| $22.41 | -0.82 | -3.5% | $23.17 | $23.41 | $22.12 | 1,090,085 | |
| $23.23 | -2.34 | -9.2% | $25.27 | $25.39 | $22.86 | 1,102,779 | |
| $25.57 | -0.08 | -0.3% | $25.77 | $26.43 | $25.20 | 1,215,889 | |
| $25.65 | -0.08 | -0.3% | $26.04 | $26.96 | $25.40 | 989,217 | |
| $25.73 | +1.30 | +5.3% | $24.58 | $25.88 | $24.40 | 2,069,688 | |
| $24.43 | +0.08 | +0.3% | $24.80 | $25.17 | $24.27 | 511,825 | |
| $24.35 | -1.08 | -4.2% | $25.58 | $26.15 | $24.15 | 1,138,620 | |
| $25.43 | +0.36 | +1.4% | $24.71 | $25.78 | $24.15 | 1,142,331 | |
| $25.07 | +3.04 | +13.8% | $23.20 | $26.36 | $23.20 | 2,066,103 | |
| $22.03 | -1.51 | -6.4% | $23.63 | $23.96 | $21.86 | 1,548,636 | |
| $23.54 | +1.53 | +7.0% | $21.41 | $23.64 | $21.27 | 2,477,607 | |
| $22.01 | -4.72 | -17.7% | $18.94 | $22.30 | $18.66 | 6,069,061 | |
| $26.73 | -1.92 | -6.7% | $27.95 | $29.49 | $26.70 | 1,158,785 | |
| $28.65 | +3.79 | +15.2% | $24.51 | $29.56 | $24.51 | 1,864,601 | |
| $24.86 | -0.27 | -1.1% | $25.22 | $25.59 | $24.61 | 603,551 | |
| $25.13 | -0.17 | -0.7% | $25.52 | $26.42 | $24.80 | 567,917 | |
| $25.30 | +0.27 | +1.1% | $24.99 | $25.59 | $24.84 | 423,512 | |
| $25.03 | +0.09 | +0.4% | $24.82 | $25.21 | $24.17 | 423,798 | |
| $24.94 | -1.19 | -4.6% | $25.88 | $25.88 | $24.91 | 217,500 | |
| $26.13 | -0.09 | -0.3% | $26.17 | $26.69 | $25.92 | 253,994 | |
| $26.22 | -0.47 | -1.8% | $26.63 | $26.79 | $26.03 | 286,933 | |
| $26.69 | +0.60 | +2.3% | $26.47 | $26.99 | $26.30 | 317,813 | |
| $26.09 | +0.04 | +0.2% | $25.99 | $26.42 | $25.18 | 321,120 | |
| $26.05 | +0.36 | +1.4% | $25.95 | $26.81 | $25.95 | 493,596 | |
| $25.69 | -1.12 | -4.2% | $26.36 | $26.36 | $25.08 | 324,478 | |
| $26.81 | +0.77 | +3.0% | $26.69 | $26.98 | $26.27 | 303,631 | |
| $26.04 | -0.18 | -0.7% | $26.30 | $26.71 | $25.63 | 341,493 | |
| $26.22 | +0.93 | +3.7% | $25.00 | $27.06 | $24.98 | 596,344 | |
| $25.29 | +0.27 | +1.1% | $24.92 | $25.53 | $24.61 | 420,526 | |
| $25.02 | -0.28 | -1.1% | $25.33 | $25.45 | $24.83 | 528,378 | |
| $25.30 | +0.12 | +0.5% | $25.49 | $25.65 | $24.89 | 478,347 | |
| $25.18 | -1.07 | -4.1% | $26.25 | $26.45 | $24.75 | 730,128 | |
| $26.25 | -0.26 | -1.0% | $26.42 | $26.81 | $25.92 | 439,504 | |
| $26.51 | -0.45 | -1.7% | $27.38 | $27.82 | $26.14 | 820,623 | |
| $26.96 | +1.25 | +4.9% | $25.69 | $27.33 | $25.68 | 776,085 | |
| $25.71 | -6.82 | -21.0% | $29.00 | $30.59 | $25.46 | 2,741,985 | |
| $32.53 | +0.49 | +1.5% | $32.21 | $32.99 | $31.92 | 396,456 | |
| $32.04 | +0.16 | +0.5% | $31.06 | $32.56 | $30.82 | 507,315 | |
| $31.88 | -1.18 | -3.6% | $33.06 | $33.06 | $31.12 | 712,733 | |
| $33.06 | +1.95 | +6.3% | $31.39 | $33.26 | $31.06 | 854,048 | |
| $31.11 | +0.23 | +0.7% | $31.32 | $31.80 | $30.16 | 496,080 | |
| $30.88 | -0.18 | -0.6% | $31.21 | $31.71 | $30.38 | 410,197 | |
| $31.06 | +0.43 | +1.4% | $30.79 | $32.26 | $30.79 | 473,786 | |
| $30.63 | -0.17 | -0.6% | $31.08 | $31.08 | $30.02 | 646,283 | |
| $30.80 | +0.21 | +0.7% | $30.13 | $30.80 | $29.70 | 435,476 | |
| $30.59 | -1.26 | -4.0% | $32.27 | $32.27 | $30.55 | 470,563 | |
| $31.85 | +0.795 | +2.6% | $31.07 | $31.96 | $31.05 | 353,204 | |
| $31.06 | -1.075 | -3.3% | $32.00 | $33.05 | $31.03 | 348,454 |
- Ticker
- NASDAQ:TYRA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 14, 2026
Tyra Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 47 slides
Latest news
Tyra Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Sep 14, 2026
Closed $25.07 (+13.8%) on Sep 14, 2026
Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratinib
Sep 9, 2026
Closed $22.01 (-17.7%) on Sep 9, 2026
Tyra Biosciences to Present at the Cantor Global Healthcare Conference
Sep 8, 2026
Closed $22.01 (-17.7%) on Sep 9, 2026
Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026
Sep 4, 2026
Closed $28.65 (+15.2%) on Sep 4, 2026
Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights
Aug 4, 2026
Closed $25.71 (-21.0%) on Aug 5, 2026
Financings
Public offering of common stock and pre-funded warrants
Sep 14, 2026
Announced: about US$400M · US$22.03 a share · Jefferies +7
Dealers: Jefferies (co-lead), Guggenheim Securities (co-lead), Cantor (co-lead), Barclays (co-lead), William Blair (co-lead), Wedbush PacGrow, Raymond James, Oppenheimer & Co.
Buyers: RA Capital Management (led the offering); Invus; Commodore Capital; BVF Partners; Janus Henderson Investors; Trails Edge Capital Partners; Integral Health Asset Management; TCGX; StemPoint Capital LP
Use of proceeds: Advance dabogratinib development in LG-UTUC, IR NMIBC and achondroplasia, preclinical and discovery programs, working capital and general corporate purposes
Decks
Investor Presentation (September 2026)
Investor deck · 47 slides · September 2026
Corporate Update (October 2024)
Corporate update · 38 slides · Oct 25, 2024
ENA Symposium (Abstract 500 LBA)
Conference · 23 slides
Tyra Biosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 13 in the last 12 months · 65 in all · newest Sep 14, 2026 · oldest 2021
- Decks
- 3 decks · latest September 2026
Where Tyra Biosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:TYRA · Home listing · This page | NASDAQ | United States | USD |
| BOATS:TYRA | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Tyra Biosciences, Inc.